Nouvelle Ivoire Cosmetique NICOS · 66-41 · IVORY COAST
For Nouvelle Ivoire Cosmetique NICOS · 66-41 · IVORY COAST, import alert is 66-41; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; country is IVORY COAST; product is PIMENT Doux plus FACE WHITENING CREAM | PIMENT Doux plus FACE WHITENING CREAM; product code is 53 L - - 06 Moisturizing (Skin Care Preparations) | 66 V - - 99 Miscellaneous Patent Medicines, Etc; date published is 04/10/2024; address is 03 BP 659 Abidjan 03 , Abidjan, IVORY COAST, verified against its source on 2026-09-16.
- Firm
- Nouvelle Ivoire Cosmetique NICOS verified
- Import alert
- 66-41
- Import alert name
- Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
- Country
- IVORY COAST verified
- Address
- 03 BP 659 Abidjan 03 , Abidjan, IVORY COAST verified
- Date published
- 04/10/2024 verified
- Product code
- 53 L - - 06 Moisturizing (Skin Care Preparations) | 66 V - - 99 Miscellaneous Patent Medicines, Etc. each item verified
- Product
- PIMENT Doux plus FACE WHITENING CREAM | PIMENT Doux plus FACE WHITENING CREAM each item verified
- FDA notes
- Products appear to be new drugs as defined by section 201(g)(1) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. 321(g)(1). As such, “PIMENT Doux plus FACE WHITENING CREAM” appears to be an unapproved new drug in violation of section 505(a) of the FD&C Act, 21 U.S.C. 355(a). Introduction or delivery for introduction of “PIMENT Doux plus FACE WHITENING CREAM” into interstate commerce violates sections 301(d) and (a) of the FD&C Act, 21 U.S.C. 331(d) and (a). Based on its labeled intended uses, “PIMENT Doux plus FACE WHITENING CREAM” is a “drug” as defined by section 201(g)(1)(B) of the FD&C Act, 21 U.S.C. 321(g)(1)(B), because it is intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease, and/or under section 201(g)(1)(C) of the FD&C Act, 21 U.S.C. 321(g)(1)(C), because it is intended to affect the structure or any function of the body. Specifically, this product is intended for use as a skin bleaching drug product. | Products appear to be new drugs as defined by section 201(g)(1) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. 321(g)(1). As such, “PIMENT Doux plus FACE WHITENING CREAM” appears to be an unapproved new drug in violation of section 505(a) of the FD&C Act, 21 U.S.C. 355(a). Introduction or delivery for introduction of “PIMENT Doux plus FACE WHITENING CREAM” into interstate commerce violates sections 301(d) and (a) of the FD&C Act, 21 U.S.C. 331(d) and (a). Based on its labeled intended uses, “PIMENT Doux plus FACE WHITENING CREAM” is a “drug” as defined by section 201(g)(1)(B) of the FD&C Act, 21 U.S.C. 321(g)(1)(B), because it is intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease, and/or under section 201(g)(1)(C) of the FD&C Act, 21 U.S.C. 321(g)(1)(C), because it is intended to affect the structure or any function of the body. Specifically, this product is intended for use as a skin bleaching drug product. each item verified
What the source says
Nouvelle Ivoire Cosmetique NICOS Date Published : 04/10/2024 03 BP 659 Abidjan 03 , Abidjan, IVORY COAST 53 L - - 06 Moisturizing (Skin Care Preparations) Date Published: 04/10/2024 Desc: PIMENT Doux plus FACE WHITENING CREAM Notes: Products appear to be new drugs as defined by section 201(g)(1) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. 321(g)(1). As such, “PIMENT Doux plus FACE WHITENING CREAM” appears to be an unapproved new drug in violation of section 505(a) of the FD&C Act, 21 U.S.C. 355(a). Introduction or delivery for introduction of “PIMENT Doux plus FACE WHITENING CREAM” into interstate commerce violates sections 301(d) and (a) of the FD&C Act, 21 U.S.C. 331(d) and (a). Based on its labeled intended uses, “PIMENT Doux plus FACE WHITENING CREAM” is a “drug” as defined by section 201(g)(1)(B) of the FD&C Act, 21 U.S.C. 321(g)(1)(B), because it is intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease, and/or under section 201(g)(1)(C) of the FD&C Act, 21 U.S.C. 321(g)(1)(C), because it is intended to affect the structure or any function of the body. Specifically, this product is intended for use as a skin bleaching drug product. 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 04/10/2024 Desc: PIMENT Doux plus FACE WHITENING CREAM Notes: Products appear to be new drugs as defined by section 201(g)(1) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. 321(g)(1). As such, “PIMENT Doux plus FACE WHITENING CREAM” appears to be an unapproved new drug in violation of section 505(a) of the FD&C Act, 21 U.S.C. 355(a). Introduction or delivery for introduction of “PIMENT Doux plus FACE WHITENING CREAM” into interstate commerce violates sections 301(d) and (a) of the FD&C Act, 21 U.S.C. 331(d) and (a). Based on its labeled intended uses, “PIMENT Doux plus FACE WHITENING CREAM” is a “drug” as defined by section 201(g)(1)(B) of the FD&C Act, 21 U.S.C. 321(g)(1)(B), because it is intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease, and/or under section 201(g)(1)(C) of the FD&C Act, 21 U.S.C. 321(g)(1)(C), because it is intended to affect the structure or any function of the body. Specifically, this product is intended for use as a skin bleaching drug product.
— accessdata.fda.gov, retrieved 2026-09-15
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_190.html
This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.